Novo Wants High Court To Clarify Foreign Company Liability
Novo Nordisk A/S has asked the U.S. Supreme Court to review an Oregon state court's decision to assert jurisdiction over it in a suit alleging its hormone therapy drug Activella caused...To view the full article, register now.
Already a subscriber? Click here to view full article